Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SRBNK: SpareBank 1 SR-Bank - Supervisory Review and Evaluation Process (SREP)

The Financial Supervisory Authority of Norway ("the FSA") regularly carries out a Supervisory Review and Evaluation Process,  "SREP", where they evaluate SpareBank 1 SR-Bank ASA’s risks and capital needs. The SREP includes a decision regarding the Pillar 2 Requirement and the Pillar 2 Guidance. SpareBank 1 SR-Bank ASA has now received this year's decision from the FSA. The Requirement is meant to cover risks which the bank is exposed to, and which is not, or only partially, covered by the Pillar 1 regulation. The Pillar 2 Requirement must be met with common equity tier 1 (CET1) capital.

Change in number of shares and votes in Episurf Medical

Episurf Medical AB (NASDAQ: EPIS B): On behalf of shareholders in Episurf Medical AB, conversion of class A-shares to B-shares were carried out during April in accordance with the Articles of Association. Through the conversions, the number of A-shares has decreased by 318,537, and the number of B-shares has increased by the same amount. The total number of shares amounts to 266,539,986, of which 479,357 are A-shares and 266,060,629 are B-shares. The total number of votes after the conversions amounts to 267,498,700.

Enersense International Plc’s January-March 2022 Business Review: Result improved significantly – successful corporate transactions in green energy

Enersense International PlcStock Exchange Release 29 April 2022 at 12:00 p.m.This release is a summary of Enersense International Plc’s January-March 2022 Business Review. Thecomplete report is attached to this release as a pdf file. It is also available on the company’s website at www.enersense.com/investors.  January–March 2022 • Revenue EUR 53.8 million (53.3), 0.9% year-on-year • EBITDA EUR 5.4 million (1.7), EBITDA margin 10.1% (3.2) • Operating profit EUR 3.2 million (-0.6), profit margin 6.0% (-1.2) • The order backlog stood at EUR 295,5 million (309,0) at the

Tele2 steps up collaboration with Reach for Change

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) has for more than 10 years worked together with Reach for Change to make life better for 4.3 million children and young people by supporting social entrepreneurs and their activities. This collaboration is now being expanded in line with Tele2's ambition to lead in sustainability and Reach for Change's global goal of reaching 30 million children and young people by 2030.– To achieve the Agenda 2030 goals we need to strive for change across all sectors. We believe that Tele2 can make a bigger difference by deepening our

Solwers Plc - Managers' Transactions

Solwers Plc Company release 29 April 2022 at 12:00 EEST Solwers Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: John LindahlPosition: Member of the Board/Deputy member Issuer: Solwers OyjLEI: 7437002BMPCI7Q5PN611Notification type: INITIAL NOTIFICATIONReference number: 13224/4/4____________________________________________ Transaction date: 2022-04-29Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000452545Nature of the transaction: ACQUISITION

World Shipping Council welcomes EU Parliament Transport Committee Opinion on the EU ETS

Brussels, 29 April 2022 – On April 28[th], the MEPs serving on the TRAN Committee voted to adopt their opinion and proposed amendments as input to the European Parliament’s consideration of the EU ETS revision.Regulation to include shipping in the EU ETS is under development as part of the EU Green Deal, a great opportunity for the EU to contribute to the transition to zero carbon for international shipping. The European Commission proposal is now under review by the European Parliament, with the EP ENVI Committee holding the lead rapporteur role and EP TRAN Committee providing input guided

Summary from Annual Report 2021: Brain+ (BRAINP) is ahead of its IPO plan

“We are dedicated to helping people with dementia and Alzheimer’s disease – their families and their caregivers – through the use of our unique Digital Therapeutic software solutions that are being developed and validated through rigorous scientific and clinical trials. 2021 brought us closer to this core objective and we are now in a strong position to launch our first dementia product in 2023, 2 years ahead of plan. This will be a highly important commercial first step towards leadership in an emerging US billion-dollar market”, said Kim Baden-Kristensen, CEO of Brain+.The following is a

Annual Report 2021 for Brain+ A/S

Brain+ annual report for 2021 is now available on the Company´s websiteThe annual report including the auditor’s report is available as an attached file and can also be read on the Company's website at https://www.brain-plus.com/ Contact Information CEO, Kim Baden-Kristensen + 45 31393319, E-mail: kim@brain-plus.com, Brain+ A/S, Købmagergade 53, 3. Certified Advisor: Keswick Global AG, + 43 1 740 408045 , E-mail: info@keswickglobal.com ( info@keswickglobal.com) About BRAIN+ [BRAINP] The mission of Brain+ is to restore patients’ independence and quality of life by treating and

Norse Atlantic Airways launches ticket sales between Norway and the United States with one-way fares starting from NOK 995 and $129

Today, Norse Atlantic Airways has opened ticket sales for flights between Norway and the United States with the full launch of www.flynorse.com. This marks a milestone for the company and heralds a new era for consumers seeking good value, choice and friendly service when choosing to travel across the Atlantic.Fares will start from an unprecedented NOK 995 and $129 one-way, including all applicable taxes. The first flight departing from Oslo to New York (JFK) will take place on 14th June. The airline will also serve Fort Lauderdale (FLL), Orlando (MCO) and Los Angeles (LAX) from Oslo.  “

Change in number of shares and votes in Beijer Electronics Group

The total number of shares in Beijer Electronics Group AB as per April 29, 2022 amounts to 29,051,688, divided into 28,768,324 ordinary shares and 283,364 class C shares, corresponding to a total of 28,796,660.4 votes.The increased number of shares and votes is due to a new share issue of 99,750 class C shares within the company’s incentive program LTI 2021/2024. The company holds all class C shares. The shares are intended to be used for hedging of obligations under the incentive program.

BioStock: Elicera continues to deliver proof-of-concept data

Swedish cell and gene therapy company Elicera Therapeutics has achieved preclinical proof-of-concept in two of its immuno-oncology projects. iTANK, a universal CAR T-cell enhancement technology platform, reached proo-of-concept late last year, and the data was published in a high impact journal earlier this month.  Most recently, Elicera announced concluding proof-of-concept studies with ELC-201, a next-generation oncolytic virus aimed at treating a wide range of tumour indications.Read the article at biostock.se: https://www.biostock.se/en/2022/04/elicera-continues-to-deliver-proof-of-

BioStock: Pila Pharma takes XEN-D0501 into pain management

After focusing solely on diabetes as a development track for candidate XEN-D0501, Pila Pharma is now taking the next step of its journey filing an application for Orphan Drug Designation in the U.S. If this is approved, it will allow the company to expand its pipeline by adding a new indication. BioStock contacted CEO Dorte X. Gram to find out more about the venture and first quarter of the year.Read the full article at biostock.se:https://www.biostock.se/en/2022/04/pila-pharma-takes-xen-d0501-into-pain-management/This is a press release from BioStock - Connecting Innovation & Capital.

Number of shares and votes in Calliditas Therapeutics

During April, Calliditas Therapeutics AB (publ) has allotted 830,586 common shares within the company’s warrant program issued in 2018. Thus, as of April 29, 2022, the number of shares and votes in the company amounts to 53,172,170. For further information, please contact: Mikael Widell, Investor relations Tel.: +46 703 11 99 60, email: mikael.widell@calliditas.com The information in the press release is such that Calliditas Therapeutics AB (publ) is required to disclose pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication,

Terveystalo’s subsidiary Feelgood acquires Jobbhälsan i Norr

Press release 29 April 2022 at 11:00 EEST   Terveystalo’s subsidiary Feelgood Svenska AB has today signed an agreement to acquire Jobbhälsan i Norr AB, a strong player in occupational health in Piteå, Sweden. The acquisition is part of Feelgood's growth strategy and strengthens its position in Norrbotten region as a leading health company for today’s working life.   “A central part of our strategy is to strengthen our local presence in important markets. Norrbotten is a region with strong economic growth and Jobbhälsan i Norr has a good reputation and some well-known, large

Dicot presenting on Aktiedagen in Stockholm

Press release: Uppsala, April 29, 2022. On Monday May 2, CEO Elin Trampe will be on the Opera Terrace stage presenting Dicot during the event Aktiedagen Stockholm.Dicot's CEO Elin Trampe will give her presentation at 09:00 on Monday May 2, where she will talk about the future for the company's potency drug development and the results achieved so far. Aktiedagen Stockholm is a hybrid event arranged by Aktiespararna that both takes place physically on the Opera Terrace and is broadcasted live via YouTube. To register for the event, please go here: Registrering Aktiedagen Stockholm 

Diamyd® meta-analysis is now available as Open Access publication

An updated large-scale Diamyd[®] meta-analysis, recently published in the peer-reviewed scientific journal Diabetes, Obesity and Metabolism, is now freely available as Open Access. The published analysis, first announced on April 20, 2022, that supports the efficacy of the therapeutic diabetes vaccine Diamyd[®][ ]in individuals recently diagnosed with Type 1 Diabetes carrying the genetic HLA DR3-DQ2 haplotype, can be accessed for free at https://doi.org/10.1111/dom.14720 About Diamyd MedicalDiamyd Medical develops precision medicine therapies for type 1 diabetes. The diabetes

Number of shares and votes in Medicover

The number of votes in Medicover AB (publ) (“Medicover ”) has changed as a result of conversions of in total 150,000 class A shares into B shares carried out in April following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 151,935,195 shares in Medicover, of which 77,399,276 are class A shares, together carrying 77,399,276 votes, 70,951,275 are class B shares, together carrying 7,095,127.5 votes and 3,584,644 are class C

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them in Penneo A/S

Company Announcement No. 15-2022Copenhagen, 29 April 2022 In accordance with the Market Abuse Regulation, Penneo must notify Finanstilsynet and publicly disclose transactions made by persons discharging managerial responsibilities and persons closely associated with them on trading of Penneo shares.  Penneo hereby notify and submit the following transaction of shares in Penneo as per appendix A

Amapola to expand service at Stockholm Arlanda with a new route to the Finnish city of Kokkola during the summer

The Swedish carrier Amapola is expanding its route network to Finland and will offer direct service from Stockholm Arlanda Airport to Kokkola, on the coast of the Gulf of Bothnia, during the peak summer season. For a number of years, there has been no air connection between Stockholm and the coastal city of Kokkola in central Finland. The Swedish airline Amapola is now picking up the route and will offer non-stop service to Kokkola for four weeks during the summer. Between July 7 and August 7, Amapola Airlines will offer non-stop service between Stockholm Arlanda (ARN) and Kokkola-

Resqunit AB - Annual Report 2021

Correction:[This correction is published because the MAR label should not have been included in the previous message]Resqunit AB (publ) ("Resqunit") April 29th, 2022, at 09.30 CET. This is the annual report for the financial year 2021, including the auditor's report. The annual report has been audited by the Company's auditor and is available on the Company's website www.resqunit.com. Certified AdvisorMangold Fondkommission AB  I  08-503 015 61  I  ca@mangold.se For additional information, please contact:Helge Trettø Olsen, CEO, Resqunit ABEmail: helge@resqunit.comPhone:

Balder and Serneke develop new block in Karlastaden

Fastighets AB Balder and Serneke are continuing their joint development work in Karlastaden. The parties have agreed to develop the Auriga block together, which will be the third tallest residential building in Gothenburg with a height of approximately 125 metres.Through two transactions, Serneke has transferred the property in question to the company jointly owned by the parties, Karlastaden Group AB, the JV company that was established in connection with a previous transaction at mid-year 2021. The first transaction covers the higher part of the property and the second one covers the

Metacon presents financial targets and brings forward the publication of the Q1 report

The Board of Directors of Metacon AB has today decided on financial targets in the medium term. The financial targets are that the company's turnover for 2025 shall exceed SEK 500 million and that the company shall be cash flow positive by the end of 2025. The Board of Directors has also decided to bring forward the company's quarterly report for the first quarter of 2022 to 13 May.The Board of Directors estimates that the need for hydrogen will grow strongly and that the transition to green hydrogen from fossil fuels will take place earlier than previously predicted. The need to switch

There are no items matching the current filter
There are no more items matching the current filter
Back to top